Cargando…
In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida
BACKGROUND: Protein farnesylation is an important tosttranslational modification in fungi. We evaluated the antifungal activity of two farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida. METHODS: Disk diffusion assay and broth microdilution assay were used to determi...
Autores principales: | Qiao, Jianjun, Gao, Peiping, Jiang, Xiaoling, Fang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029545/ https://www.ncbi.nlm.nih.gov/pubmed/24314136 http://dx.doi.org/10.1186/1476-0711-12-37 |
Ejemplares similares
-
The Aspergillus fumigatus farnesyltransferase β-subunit, RamA, mediates growth, virulence, and antifungal susceptibility
por: Norton, Tiffany S., et al.
Publicado: (2017) -
Bioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni
por: Probst, Alexandra, et al.
Publicado: (2019) -
An overview on natural farnesyltransferase inhibitors for efficient cancer therapy
por: Dai, Xiaohan, et al.
Publicado: (2020) -
Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase
por: Weber, Lea, et al.
Publicado: (2021) -
Sphingosine as a New Antifungal Agent against Candida and Aspergillus spp.
por: Hashemi Arani, Fahimeh, et al.
Publicado: (2022)